The Pharmacy Times® Pharmacy Hospital Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to hospital and health-system pharmacists.
June 7th 2023
It’s time for pharmacies to take a page out of the books of hospitals and tech companies by expanding and streamlining their use of contingent labor.
Bivalent RSV Prefusion F Vaccine Reduces Lower, Acute Respiratory Tract IllnessApril 17th 2023
Respiratory syncytial virus (RSV) vaccine demonstrated efficacy of 66.7% in reducing RSV-associated lower respiratory tract illness with at least 2 signs or symptoms in older adults.
Pembrolizumab Plus Gemcitabine/Cisplatin Provided Significant Improvement in OS in Advanced Biliary Tract CancerApril 16th 2023
These data support using this combination therapy as a new first-line treatment option in patients with previously untreated metastatic or unresectable BTC.
Predictive Model Accurately Estimates Kidney Decline Up to 5 Years for CKD, T2DApril 14th 2023
A linear mixed-effect model for repeated estimated glomerular filtration rate measurements at baseline and a follow-up visit, up to 5 years after baseline, shows results.
Spontaneous Lobar Intracerebral Hemorrhage Associated With Higher Rate of Subsequent Major Cardiovascular EventsApril 13th 2023
The risk of a second stroke after intracerebral hemorrhage (ICH) did not differ by index hematoma location, and this risk was higher for ischemic stroke than ICH.
Anakinra Found No Worse Than Standard of Care for Mortality Outcomes Among Patients with COVID-19 PneumoniaApril 13th 2023
Patients administered anakinra did not meet a study’s primary endpoint of proportion of patients who did not need mechanical ventilation 15 days after starting treatment for severe COVID-19 pneumonia.
FDA Approves Expanded Indication for Hyqvia to Treat Pediatric Primary ImmunodeficiencyApril 12th 2023
During the 12-month trial period, Hyqvia was shown to be efficacious treating the occurrence of acute serious bacterial infections in children aged 2 through 16 years with primary immunodeficiency.
Study: Participation in Clinical Trials Associated With Improved Overall Survival in Patients with Ovarian CancerApril 12th 2023
Availability of clinical trials in the gynecologic cancer care space are increasing, but it is important to be mindful of current racial disparities.
Hard Stops for EMRs Reduces Rates of Hospital-Acquired Clostridioides difficile InfectionApril 12th 2023
These are used to help reduce inappropriate testing, where an expert consults with medical directors of infection prevention and control for a test-order override.
Two Clinical Trials Show Increased Progression-Free Survival With Addition of Immunotherapy in Endometrial CancerApril 11th 2023
Taken together, the studies point to meaningful changes in the standard of care for patients with advanced or recurrent endometrial cancer.
Study Results Show Estimated 2022 RSV Rates Could Be Twice as High as Previous 2 YearsApril 11th 2023
State-level respiratory syncytial virus hospitalization rates for 2022 could be the highest seen since 2006, analysis published in Frontiers in Pediatrics indicate.
Bivalent Prefusion F Vaccine for RSV Effective in Pregnancy to Prevent RSV in InfantsApril 11th 2023
The trial did not meet the second primary efficacy endpoint of medically attended respiratory syncytial virus-associated lower respiratory tract illness.